293 related articles for article (PubMed ID: 1851233)
1. Role of metalloproteinases in human osteoarthritis.
Woessner JF; Gunja-Smith Z
J Rheumatol Suppl; 1991 Feb; 27():99-101. PubMed ID: 1851233
[TBL] [Abstract][Full Text] [Related]
2. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
3. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
4. Degradation of extracellular matrix in osteoarthritis: 4 fundamental questions.
Malemud CJ; Martel-Pelletier J; Pelletier JP
J Rheumatol; 1987 May; 14 Spec No():20-2. PubMed ID: 3305934
[TBL] [Abstract][Full Text] [Related]
5. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan-degrading metalloproteases of human articular cartilage.
Woessner JF; Azzo WH
J Rheumatol; 1987 May; 14 Spec No():36-7. PubMed ID: 3305936
[TBL] [Abstract][Full Text] [Related]
7. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.
Nixon JS; Bottomley KM; Broadhurst MJ; Brown PA; Johnson WH; Lawton G; Marley J; Sedgwick AD; Wilkinson SE
Int J Tissue React; 1991; 13(5):237-41. PubMed ID: 1666894
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
9. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
[TBL] [Abstract][Full Text] [Related]
10. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium.
Okada Y; Shinmei M; Tanaka O; Naka K; Kimura A; Nakanishi I; Bayliss MT; Iwata K; Nagase H
Lab Invest; 1992 Jun; 66(6):680-90. PubMed ID: 1602738
[TBL] [Abstract][Full Text] [Related]
11. Studies on purified neutral proteoglycan-degrading enzyme (stromelysin/matrix metalloproteinase 3) from human articular cartilage.
Gunja-Smith Z; Nagase H; Woessner JF
Matrix Suppl; 1992; 1():82-3. PubMed ID: 1480097
[No Abstract] [Full Text] [Related]
12. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
13. Production of cytokines by chondrocytes and its role in proteoglycan degradation.
Shinmei M; Masuda K; Kikuchi T; Shimomura Y; Okada Y
J Rheumatol Suppl; 1991 Feb; 27():89-91. PubMed ID: 2027138
[TBL] [Abstract][Full Text] [Related]
14. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
Reynolds JJ; Meikle MC
J R Coll Surg Edinb; 1997 Jun; 42(3):154-60. PubMed ID: 9195805
[TBL] [Abstract][Full Text] [Related]
15. [Proteolytic enzymes and the destruction of articular cartilage in arthritis and chronic polyarthritis].
Mohamed-Ali H
Wien Med Wochenschr; 1991; 141(4):77-85. PubMed ID: 1645488
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
Alexander JP; Bradley JM; Gabourel JD; Acott TS
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
[TBL] [Abstract][Full Text] [Related]
17. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
18. Osteoarthritis in the temporo-mandibular joint (TMJ) of aged mice and the in vitro effect of TGF-beta 1 on cell proliferation, matrix synthesis, and alkaline phosphatase activity.
Livne E; Laufer D; Blumenfeld I
Microsc Res Tech; 1997 May; 37(4):314-23. PubMed ID: 9185153
[TBL] [Abstract][Full Text] [Related]
19. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P
Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD
Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
